Vulnerability of small GABAergic neurons to human β-amyloid pentapeptide

Brain Research

Volumn 796, Issue 1-2, 1998, Pages 239-246

  Pakaski, Magdolna ^a   Farkas, Zoltan ^a   Kasa Jr , Peter ^a   Forgon, Monika ^a   Papp, Henrietta ^a   Zarandi, Marta ^a   Penke, Botond ^a   Kasa Sr , Peter ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alzheimer's disease; Amyloid; GABA immunocytochemistry; Image analysis; Neuronal culture; Scanning electron microscopy

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMYLOID; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; FOREBRAIN; GABAERGIC SYSTEM; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SENILE PLAQUE;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; DRUG RESISTANCE; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; NEURONS; PEPTIDE FRAGMENTS; RATS;

EID: 0032526538     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00358-8     Document Type: Article

References (39)

1. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
2. Bennett B.D., Bolam J.P. Characterization of calretinin-immunoreactive structures in the striatum of the rat. Brain Res. 609:1993;137-148.
3. Busciglio J., Lorenzo A., Yankner B.A. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging. 13:1992;609-612.
4. Cheng B., Mattson M.P. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron. 7:1991;1031-1041.
5. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
6. Emre M., Geula C., Ransil B.J., Mesulam M.-M. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β amyloid in the rat brain. Neurobiol. Aging. 13:1992;553-560.
7. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport. 4:1993;523-526.
8. Freund T.F. GABAergic septohippocampal neurons contain parvalbumin. Brain Res. 478:1989;375-381.
9. Hardy J., Cowburn R., Barton A., Reynolds G., Dodd P., Wester P., O'Carrol A.-M., Lofdahl E., Winblad B. A disorder of cortical GABAergic innervation in Alzheimer's disease. Neurosci. Lett. 73:1987;192-196.
10. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91:1994;3270-3274.
11. Kasa P., Pakaski M., Penke B. Synthetic human beta amyloid has selective vulnerable effects on different types of neurons and glial cells in in vitro cultures derived from embryonic rat brain cortex. Neurobiol. Aging. 13:1992;S104. Suppl. 1.
12. P. Kasa, M. Pakaski, B. Penke, Synthetic human beta amyloid has selective vulnerable effects on different types of neurons, in: M. Nicolini, P.F. Zatta, B. Corain, (Eds.), Alzheimer's Disease and related disorders, Advances in the Biosciences, Vol. 12, Pergamon Press, Oxford, 1993, pp. 311-312.
13. Kasa P., Farkas Z., Pakaski M., Soós K., Penke B. Effects of β-amyloid peptides and their fragments on acetylcholine release in in vitro studies. Clin. Neurosci. 49:1996;48-49.
14. Kita H., Kosaka T., Heizmann C.V. Parvalbumin-immunoreactive neurons in the rat neostriatum: a light and electron microscopic study. Brain Res. 536:1990;1-15.
15. Kowall N.W., Beal M.F., Busciglio J., Duffy L.K., Yankner B.A. An in vivo model for neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7247-7251.
16. Kowall N.W., McKee A.C., Yankner B.A., Beal M.F. In vivo neurotoxicity of beta amyloid [β(1-40)] and the [β(25-35)] fragment. Neurobiol. Aging. 13:1992;537-542.
17. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7951-7955.
18. Manelli A.M., Puttfarcken P.S. β-Amyloid-induced toxicity in rat hippocampal cells: in vitro evidence for the involvement of free radicals. Brain Res. Bull. 38:1995;569-576.
19. Marczynski T.J. GABAergic deafferentation hypotheses of brain aging and Alzheimer's disease revisited. Brain Res. Bull. 45:1998;341-379.
20. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
21. Mattson M.P., Tomaselli K.J., Rydel R.E. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621:1993;35-49.
22. Miettinen R., Gulyas A.I., Baimbridge K.G., Jacobowitz D.M., Freund T.F. Calretinin is present in non-pyramidal cells of rat hippocampus: II. Co-existence with other calcium binding proteins and GABA. Neuroscience. 48:1992;29-43.
23. 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains Exp. Brain Res. 102:1995;503-510.
24. Pakaski M., Soós K., Penke B., Kasa P. Neurotoxic effects of beta-amyloid and different amyloid peptides on cholinergic, gabaergic and parvalbumin containing neurons. Clin. Neurosci. 49:1996;24.
25. Papp H., Pakaski M., Penke B., Kasa P. Effects of β-amyloid and its fragments on cholinergic and cholinoceptive neurons in vitro. Clin. Neurosci. 49:1996;49-50.
26. B. Penke, K. Soós, Z.E. Szabó, J. Márky-Zay, M. Pakaski, P. Kasa, Synthesis and investigation of the β-amyloid 1-42 polypeptide and its analogs, in: C.H. Schneider, A.N. Eberle, (Eds.), Peptides, Escom Science Publishers, 1992, pp. 792-793.
27. Perry E.K., Court J.A., Lloyd S., Johnson M., Griffiths M.H., Spurden D., Piggott M.A., Turner J., Perry R.H. Beta amyloidosis in normal aging and transmitter signalling in human temporal lobe. Ann. New York Acad. Sci. 777:1996;388-392.
28. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
29. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207:1991;367-368.
30. Pike C.J., Cotman C.W. Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid. Neuroscience. 56:1993;269-274.
31. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
32. Pike C.J., Cotman C.W. Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vitro. Brain Res. 671:1995;293-298.
33. Pike C.J., Walencewicz A.J., Kosmoski J., Cribbs D.H., Glabe C.G., Cotman C.W. Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64:1995;253-265.
34. J.H. Rogers, Immunohistochemical markers in rat cortex: co-localization of calretinin and calbindin-D28k with neuropeptides and GABA, Brain Res. (1992) 147-157.
35. Rush D.K., Aschmies S., Merriman M.C. Intracerebral β-amyloid (25-35) produces tissue damage: is it neurotoxic? Neurobiol. Aging. 13:1992;591-594.
36. Storga D., Vrecko K., Birkmayer J.G., Reibnegger J.G. Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients. Neurosci. Lett. 203:1996;29-32.
37. Tohgi H., Abe T., Takahashi S., Kimura M. A selective reduction of excitatory amino acids in cerebrospinal fluid of patients with Alzheimer type dementia compared with vascular dementia of the Binswanger type. Neurosci. Lett. 141:1992;5-8.
38. Waite J., Cole G.M., Frautschy S.A., Connor D.J., Thal L.J. Solvent effects on beta protein toxicity in vivo. Neurobiol. Aging. 13:1992;595-599.
39. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.